TATA Health International Holdings Ltd. (HK:1255) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TATA Health International Holdings Ltd. faces continued trading suspension on the Hong Kong Stock Exchange due to delays in publishing financial results for 2023 and the first half of 2024, and must satisfy resumption guidance by October 1, 2025, to avoid delisting. The company, primarily engaged in footwear alongside financial services, healthcare, and online medical services, is operating most of these sectors at minimal levels and is working on an action plan to resume trading.
For further insights into HK:1255 stock, check out TipRanks’ Stock Analysis page.